Laudani, C.; Giacoppo, D.; Greco, A.; Ortega-Paz, L.; El Khoury, G.; Capodanno, D.; Angiolillo, D.J.
Antiplatelet Monotherapies for Long-Term Secondary Prevention Following Percutaneous Coronary Intervention. J. Clin. Med. 2025, 14, 5536.
https://doi.org/10.3390/jcm14155536
AMA Style
Laudani C, Giacoppo D, Greco A, Ortega-Paz L, El Khoury G, Capodanno D, Angiolillo DJ.
Antiplatelet Monotherapies for Long-Term Secondary Prevention Following Percutaneous Coronary Intervention. Journal of Clinical Medicine. 2025; 14(15):5536.
https://doi.org/10.3390/jcm14155536
Chicago/Turabian Style
Laudani, Claudio, Daniele Giacoppo, Antonio Greco, Luis Ortega-Paz, Georges El Khoury, Davide Capodanno, and Dominick J. Angiolillo.
2025. "Antiplatelet Monotherapies for Long-Term Secondary Prevention Following Percutaneous Coronary Intervention" Journal of Clinical Medicine 14, no. 15: 5536.
https://doi.org/10.3390/jcm14155536
APA Style
Laudani, C., Giacoppo, D., Greco, A., Ortega-Paz, L., El Khoury, G., Capodanno, D., & Angiolillo, D. J.
(2025). Antiplatelet Monotherapies for Long-Term Secondary Prevention Following Percutaneous Coronary Intervention. Journal of Clinical Medicine, 14(15), 5536.
https://doi.org/10.3390/jcm14155536